MedTrace Logo

Safe and Explainable AI

NCT06694181 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300000

Last updated 2026-02-25

No results posted yet for this study

Summary

While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical knowledge effectively, making AI recommendations explainable to clinicians, and establishing safety guarantees.

Conditions

Interventions

OTHER

AI-PERSONALIZED CLINICAL DECISION SUPPORT

AI-ENABLED DECISION MAKING FOR PERSONALIZED CLINICAL DECISION SUPPORT

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-29
Primary Completion
2028-11-30
Completion
2028-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06694181 on ClinicalTrials.gov